Elite Pharmaceuticals Inc (ELTP)

[NASDAQ2020]

20 Pathways to DollarLand

Any One of these will get us there in 2019-2020
1.) SunGen ANDA #2 (Avatar) $1.6 Billion market 4 competitors: Approval Imminent
2.) SunGen ANDA #5 greater than $1.6 Billion market FDA filing imminent
3.) SequestOx® First ever Immediate Release ADF labeled opiod with ORAL, IV, and Nasal ADF Labeling (chewing) The Holy Grail of IR opioids
4.) Approval/Launch of First Ever Abuse Deterrent Generic Reformulated OxyContin® filed watch for approval in 2019
5.) First to market Generic ER 2 bead ADF Oxycodone ELI-201
6.) Unique-Novel ADF Without Naltrexone pilot study completed and
90% cheaper than the competitions ADF
7.) Launch first four SunGen generics (2016) ($3 Billion combined markets) The two SunGen deals have a combined market worth $6 billion
8.) Buyout / Acquisition
9.) BP Partnership for entire ADF line
10.) Uplisting to NASDAQ exchange
11.) Merger
12.) Complete PH III trials for the first ever 24 hour
13.) Generic of Reformulated Opana® ER
14.) First ADF opiod for Chinese Pain Market --PuraCap/Humanwell
15.) Canadian Approval of SequestOx® - patents in place
16.) FDA accepts citizen petition urging the FDA to phase out oral prescription opioid analgesics that lack abuse-deterrent properties
17.) Approval of Isradipine for Parkinson’s Disease
18.) Launch additional 2017 SunGen generics brings the market to $6 billion
19.) Chinese approval of SequestOx® Chinese meeting Feb 2017
20.) European approval of AD oxycodone/opiod - patents in place

Which one will get us there first ?
Isradipine?